>
Panacea Global Inc logo

PANG - Panacea Global Inc Share Price

$0 -0.1  -99.9%

Last Trade - 21/12/17

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 6858
Bullish
Bearish
Unlock PANG Revenue
Momentum
Relative Strength (%)
1m -99.9%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2008 2009 2010 2011 2012 2013 2014E 2015E CAGR / Avg
0.000 0.003 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2014, PanaceaGlobal Inc revenues was not reported. Net loss increasedfrom $846K to $2.6M. Higher net loss reflects Stock basedcompensation increase from $0K to $803K (expense), Officeand General increase of 56% to $750K (expense), Salariesand benefits increase of 30% to $226K (expense). BasicEarnings per Share excluding Extraordinary Items decreasedfrom -$0.01 to -$0.02.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

PANG Revenue Unlock PANG Revenue

Net Income

PANG Net Income Unlock PANG Revenue

Normalised EPS

PANG Normalised EPS Unlock PANG Revenue

PE Ratio Range

PANG PE Ratio Range Unlock PANG Revenue

Dividend Yield Range

PANG Dividend Yield Range Unlock PANG Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
PANG EPS Forecasts Unlock PANG Revenue
Profile Summary

Panacea Global, Inc. is a biotechnology company focusing on developing and commercializing products for the early detection, diagnosis and monitoring the recurrence of cancer. The Company's product is a blood test that can measure the blood level of Human Aspartyl (Asparaginyl) B-Hydroxylase (HAAH). Its HAAH (a cancer biomarker) is an enzyme, which is over expressed in cancer cells. This test is recommended for men and women over 50 years of age with a history of smoking cigarettes. Its HAAH Blood Test can help the early diagnosis of prostate cancer. Its HAAH Blood Test provides the physician with additional information about the likelihood that a man with an abnormally high prostate-specific antigen (PSA) value, with or without an abnormal digital rectal examination (DRE), may have prostate cancer. Its HAAH Blood Test provides information to differentiate prostate cancer from benign conditions and to help guide patient management.

Directors
Last Annual December 31st, 2013
Last Interim September 30th, 2014
Incorporated October 9, 1995
No. of Shareholders: 1,061
No. of Employees: 3
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 106,747,586
Free Float (0.0%)
Eligible for
× ISAs
SIPPs
PANG Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PANG
Upcoming Events for PANG
Frequently Asked Questions for Panacea Global Inc
What is the Panacea Global Inc share price?

As of 21/12/17, shares in Panacea Global Inc are trading at $0, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Panacea Global Inc share price performed this year?

Shares in Panacea Global Inc are currently trading at $0 and the price has moved by -99.95% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Panacea Global Inc price has moved by -99.97% over the past year.

What are the analyst and broker recommendations for Panacea Global Inc?

Of the analysts with advisory recommendations for Panacea Global Inc, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Panacea Global Inc is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Panacea Global Inc next release its financial results?

Panacea Global Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2015-09-30
What is the Panacea Global Inc dividend yield?

Panacea Global Inc does not currently pay a dividend.

Does Panacea Global Inc pay a dividend?

Panacea Global Inc does not currently pay a dividend.

When does Panacea Global Inc next pay dividends?

Panacea Global Inc does not currently pay a dividend.

How do I buy Panacea Global Inc shares?

To buy shares in Panacea Global Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Panacea Global Inc?

Shares in Panacea Global Inc are currently trading at $0, giving the company a market capitalisation of £n/a.

Where are Panacea Global Inc shares listed? Where are Panacea Global Inc shares listed?

Here are the trading details for Panacea Global Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: PANG
What kind of share is Panacea Global Inc?

We were not able to load our ranking data for Panacea Global Inc

Is there a Panacea Global Inc share price forecast 2021?

We were not able to load any forecast data for Panacea Global Inc.

How can I tell whether the Panacea Global Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Panacea Global Inc. Over the past six months, the relative strength of its shares against the market has been -99.95%. At the current price of $0, shares in Panacea Global Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Panacea Global Inc PE Ratio?

We were not able to find PE ratio data for Panacea Global Inc.

Who are the key directors of Panacea Global Inc?

We were unable to find the directors for Panacea Global Inc.

Who are the major shareholders of Panacea Global Inc?

Here are the top five shareholders of Panacea Global Inc based on the size of their shareholding:

Similar to PANG
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.